NUTX

Nutex Health, Inc.

Fundamental data last updated:November 6, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Healthcare

industry

Medical - Care Facilities

Exchange

NASDAQ

County of HQ

United States

Next Earnings Date

Pending Announcement

Business Summary

Nutex Health, Inc. operates within the medical care facilities industry, focusing on providing comprehensive healthcare services. Its business model revolves around delivering high-quality patient care, leveraging economies of scale to maintain competitive pricing. The company's competitive moat lies in its ability to integrate cutting-edge technology, enhancing patient experiences and outcomes. By fostering strong relationships with healthcare providers and patients, Nutex Health secures a loyal customer base, ensuring steady cash flow.

 


Analyze NUTX on TradingView

VALUATION

P/E

8.11

Market Cap ($M USD)

$1.46B

Forward P/E

7.77

PEG

0.09

PRICE TO SALES

1.72

PRICE TO BOOK

3.71

EV / EBITDA

4.16

5-Year Average P/E

Free Cash Flow Yield

18.83%

DCF Value

$-439.59

Graham Number

$183.88

Price to FCF

5.31

EV to FCF

5.83

Earnings Yield

12.32%

FCF Yield

18.83%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

28.91%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$26.19

Next Year EPS Growth Estimate

$27.37

Next Year Revenue Growth Estimate

$870.47M

Return on Equity (ROE)

51.88%

FREE CASH FLOW

Operating Margin

43.02%

Debt-to-Equity

0.88

Piotroski F-Score

6

Altman Z-Score

4.36

Return on Invested Capital (ROIC)

33.39%

Current Ratio

5.00

Quick Ratio

4.96

Net Debt to EBITDA

0.37

Interest Coverage

18.42

Gross Profit margin

51.26%

FCF PER SHARE

$39.90

REVENUE PER SHARE

$123.23

Analyze NUTX on TradingView

Gainseekers Quantitative Analysis

Summary

Nutex Health, Inc. presents a perplexing valuation conundrum. Despite a Forward P/E of 7.77 and an Earnings Yield of 12.32%, the stock traded significantly below its DCF Value, suggesting potential undervaluation. However, the Graham Number indicates a more conservative intrinsic value, hinting at overvaluation. The Altman Z-score of 4.36 signals robust financial health, yet the market seems to have priced in substantial growth expectations. This juxtaposition of metrics paints a picture of a company with both promise and peril.

AI Exposure / Tech Reliance

In the rapidly evolving healthcare sector, Nutex Health, Inc. stands at the intersection of medical care facilities and technological advancement. As AI continues to revolutionize diagnostics and patient management, the company is well-positioned to integrate these innovations, enhancing operational efficiency. Its industry focus allows it to leverage tech shifts to improve patient outcomes and streamline services.

The Bull Case

For the discerning GARP investor, Nutex Health offers compelling reasons to buy. With a stellar ROIC of 33.39% and a solid FCF Yield of 18.83%, the company demonstrates exceptional capital efficiency and cash generation. The Piotroski F-Score of 6 and an Operating Margin of 43.02% further underscore its operational prowess and pricing power. These metrics suggest a business capable of sustaining growth while delivering shareholder value.

The Bear Case

Despite its strengths, Nutex Health is not without risks. The Price/Book ratio of 3.71 and Price/Sales of 1.72 indicate a potentially overvalued stock relative to its assets and revenue. Additionally, the stock's proximity to its 52-week high raises concerns about technical overextension. While the company boasts strong fundamentals, these valuation metrics suggest caution for investors wary of paying a premium.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$310.00

Institutional Ownership %

1-Year Beta

2.00

Insider Buying % (6 Mo)

Distance to 52-Week High

6.36%

Distance to 52-Week Low

60.50%

EARNINGS SURPRISE %

89.49%

50-DAY SMA

$202.62

200-DAY SMA

$150.08

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.